ONC – beigene, ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Beigene, Ltd. (NASDAQ: ONC) was given a new $259.00 price target on by analysts at Sanford C. Bernstein.
Beigene, Ltd. (NASDAQ: ONC) had its "buy" rating re-affirmed by analysts at Guggenheim.
Beigene, Ltd. (NASDAQ: ONC) was given a new $348.00 price target on by analysts at JMP Securities.
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy [Yahoo! Finance]
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy
Form 4 BeiGene, Ltd. For: Mar 18 Filed by: Wang Xiaodong
Form 4 BeiGene, Ltd. For: Mar 14 Filed by: Wu Xiaobin
Form 4 BeiGene, Ltd. For: Mar 11 Filed by: Wang Xiaodong
Form 4 BeiGene, Ltd. For: Mar 10 Filed by: OYLER JOHN
Form 4 BeiGene, Ltd. For: Mar 07 Filed by: OYLER JOHN
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.